0H68.LSE AFLAC Inc.
- Market cap
- -
- P/E
- 20.6x
- P/B
- -
- ROE
- 12.2%
- Dividend yield
- 0.02%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 0H68.LSE undervalued?
Graham numberThe Graham number of AFLAC Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AFLAC Inc. fundamental analysis
No fundamental analysis for AFLAC Inc. yet.
AFLAC Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AFLAC Inc.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance p…
Full company profileAFLAC Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
AFLAC Inc. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 22.6B | 21.7B | 21.8B | 22.3B | 22.1B | 22.1B | 19.1B | 18.7B | 18.9B | 17.2B | 16.8B |
| Gross Profit | 22.6B | 21.7B | 21.8B | 22.3B | 22.1B | 22.1B | 19.5B | 18.7B | 18.9B | 9.87B | 9.43B |
| Operating Income | 4.34B | 4.26B | 4.21B | 4.67B | 4.40B | 5.61B | 5.10B | 15.5B | 6.61B | 4.53B | 4.44B |
| EBITDA | 4.39B | 4.31B | 4.25B | 4.70B | 4.43B | 5.61B | 5.14B | 6.31B | 6.61B | 5.55B | 5.14B |
| Net Income | 2.66B | 4.60B | 2.92B | 3.30B | 4.78B | 4.33B | 4.42B | 4.66B | 5.44B | 3.65B | 3.69B |
| EPS | 3.21 | 5.77 | 3.77 | 4.43 | 6.67 | 6.39 | 6.93 | 7.78 | 9.63 | 6.82 | 7.29 |
| Balance Sheet | |||||||||||
| Total Assets | 131B | 142B | 145B | 158B | 172B | 165B | 135B | 131B | 117B | 116B | 116B |
| Total Liabilities | 110B | 117B | 121B | 129B | 139B | 131B | 115B | 109B | 91.3B | 87.0B | 85.6B |
| Shareholders' Equity | 20.5B | 24.6B | 23.5B | 29.0B | 33.6B | 33.3B | 20.1B | 22.0B | 26.1B | 21.5B | 30.3B |
| Cash & Short-term Investments | 4.86B | 3.49B | 4.34B | 4.90B | 5.14B | 5.05B | 3.94B | 4.31B | 6.23B | 6.25B | 6.12B |
| Total Debt | 5.36B | 5.29B | 5.78B | 6.67B | 7.92B | 7.97B | 7.47B | 7.24B | 7.50B | 8.41B | 8.73B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 5.99B | 6.13B | 6.01B | 5.46B | 5.96B | 5.05B | 3.88B | 3.19B | 2.71B | 2.56B | 2.16B |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | 5.99B | 6.13B | 6.01B | 5.46B | 5.96B | 5.05B | 3.88B | 3.19B | 2.71B | 2.56B | 2.16B |
| Ratios | |||||||||||
| ROE | 13.0% | 18.7% | 12.4% | 11.4% | 14.2% | 13.0% | 21.9% | 21.2% | 20.9% | 17.0% | 12.2% |
| ROA | 2.0% | 3.3% | 2.0% | 2.1% | 2.8% | 2.6% | 3.3% | 3.6% | 4.6% | 3.1% | 3.2% |
| Net Profit Margin | 11.8% | 21.2% | 13.4% | 14.8% | 21.6% | 19.6% | 23.1% | 24.9% | 28.8% | 21.2% | 22.0% |
| Debt to Equity | 0.26x | 0.22x | 0.25x | 0.23x | 0.24x | 0.24x | 0.37x | 0.33x | 0.29x | 0.39x | 0.29x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
AFLAC Inc. dividends
- Dividend yield
- 0.02%
- Forward dividend
- -
- Payout ratio
- 32.9%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 1.20B | 2.24 | 32.9% |
| 2024 | USD 1.09B | 1.92 | 20.0% |
| 2023 | USD 966M | 1.61 | 20.7% |
| 2022 | USD 979M | 1.54 | 22.2% |
| 2021 | USD 855M | 1.26 | 19.8% |
| 2020 | USD 769M | 1.07 | 16.1% |
| 2019 | USD 771M | 1.03 | 23.3% |
| 2018 | USD 793M | 1.02 | 27.2% |
| 2017 | USD 661M | 0.83 | 14.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Mar 19, 2018.
Who owns AFLAC Inc.
- Insiders 10.86%
- Institutions 59.96%
- Public & others 29.18%
- Free float 497M
AFLAC Inc. company profile
- Company name
- AFLAC Inc.
- Ticker
- 0H68.LSE
- Exchange
- London Exchange
- Sector
- Financial Services
- Industry
- Commercial Services & Supplies
- Employees
- 12,716
- Fiscal year end
- December
- Address
- 1932 Wynnton Road, Columbus, GA, United States, 31999-7251
- Phone
- 706 323 3431
- Website
- aflac.com
About AFLAC Inc.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
AFLAC Inc. management
10- Mr. Daniel Paul AmosChairman & CEO · born 1952
- Mr. Virgil Raynard MillerPresident · born 1969
- Mr. Max Kristian Broden C.F.A.Senior EVP & CFO · born 1979
- Mr. Bradley Eugene Dyslin C.F.A.Executive VP & Global Chief Investment Officer · born 1966
- Ms. Audrey Boone Tillman Esq.Senior EVP, & General Counsel · born 1965
- Ms. Robin Littrell Blackmon CPA, CGMASenior VP of Financial Services & Chief Accounting Officer · born 1964
- Mr. David A. YoungVice President of Capital Markets
- Mr. Bradley L. KnoxSenior VP & Counsel of Federal Relations
- Mr. Steven Kent BeaverExecutive Vice President; Chief Financial Officer, Aflac Life Insurance Japan · born 1965
- Mr. Timothy L. Callahan CISM, CISSP, CRISCSenior VP & Chief Information Security Officer